The best-corrected visual acuity was decreased (1.0 right, 0.8 left)
Reduced cycle life and capacity degradation
In a study of transgenic mice with a Kras G12D mutation which induces PanINs and eventually pancreatic cancer, treatment with exendin-4 increased higher grade PanIN lesions (35, 38)
Evidence from receptor blockade and GLP-1R gene knockdown experiments confirmed that the spinal cord is a primary site mediating exenatide-induced antinociception [24]
Semaglutide: Also effective for A1C reduction (1.01.8%), but not quite as potent
2025 Advances in Malignant Schwannoma Research and Treatment As of 2025, the management of malignant peripheral nerve sheath tumors (MPNSTs)particularly those associated with Neurofibromatosis type 1 (NF1)is entering a new era, driven by genomic insights, targeted therapies, and novel clinical trial strategies